CD33CART

Anti-CD33 chimeric antigen receptor-expressing T cells

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD33CART, covering 2025-07-14 to 2025-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]

See pricing